Russell Investments Group
NGM

Russell Investments Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Russell Investments Group’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-43,598
Closed -$37.5K – 3385
2023
Q4 		$37.5K Sell
43,598
-80,530
-65% -$70.7K ﹤0.01% 2666
2023
Q3 		$133K Buy
124,128
+10,933
+10% +$22.6K ﹤0.01% 2573
2023
Q2 		$293K Buy
113,195
+68,551
+154% +$245K ﹤0.01% 2385
2023
Q1 		$182K Sell
44,644
-1,042
-2% -$4.82K ﹤0.01% 2494
2022
Q4 		$229K Buy
45,686
+21,354
+88% +$134K ﹤0.01% 2540
2022
Q3 		$317K Buy
24,332
+11,832
+95% +$179K ﹤0.01% 2408
2022
Q2 		$160K Sell
12,500
-3,683
-23% -$51K ﹤0.01% 2582
2022
Q1 		$246K Sell
16,183
-4,442
-22% -$69.3K ﹤0.01% 2422
2021
Q4 		$364K Sell
20,625
-6,755
-25% -$130K ﹤0.01% 2542
2021
Q3 		$574K Buy
27,380
+7,320
+36% +$161K ﹤0.01% 2406
2021
Q2 		$393K Sell
20,060
-1,762
-8% -$41.2K ﹤0.01% 2692
2021
Q1 		$633K Sell
21,822
-12,140
-36% -$340K ﹤0.01% 2427
2020
Q4 		$1.03M Sell
33,962
-1,689
-5% -$37K ﹤0.01% 2106
2020
Q3 		$566K Sell
35,651
-5,373
-13% -$98K ﹤0.01% 2336
2020
Q2 		$807K Buy
41,024
+8,902
+28% +$170K ﹤0.01% 2169
2020
Q1 		$396K Buy
+32,122
New +$524K ﹤0.01% 2278

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Russell Investments Group's NGM Position: Q1 2024 in Review

Russell Investments Group sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q1 2024, closing a stake of 43,598 shares — an estimated $37.5K sold.

Russell Investments Group first reported a position in NGM in Q1 2020 and held it in 16 quarters. The position peaked at $1.03M in Q4 2020. 75 funds tracked by Wall St. Rank hold NGM as of Q1 2024.

  • Russell Investments Group reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Russell Investments Group sold 43,598 NGM Biopharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $37.5K.
  • Russell Investments Group first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 16 quarters.
  • Russell Investments Group's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $1.03M in Q4 2020.
  • 75 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Russell Investments Group's 13F filing for Q1 2024, filed 8 May 2024.